Prof. Dr. med. Arndt Hartmann

Lehrstuhl für Allgemeine Pathologie und Pathologische Anatomie

PBRM1 but not BAP1 deficiency is a frequent feature of multifocal non-cystic low-grade clear cell renal cell carcinoma (2019) Agaimy A, Trpkov K, Gao Y, Hartmann A, Hes O Conference contribution Characterization of esophageal inflammation in patients with achalasia. A retrospective immunohistochemical study (2019) Döhla M, Leichauer K, Gockel I, Niebisch S, Thieme R, Lundell L, Schumacher J, et al. Journal article Magnification endoscopy with optical chromoendoscopy for in vivo assessment of histological inflammation in patients with inflammatory bowel disease (2019) Klenske E, Atreya R, Hartmann A, Fischer S, Hirschmann S, Zundler S, Iacucci M, et al. Conference contribution Piwi-like 1 protein expression is a prognostic factor for renal cell carcinoma patients (2019) Stoehr C, Steffens S, Polifka I, Jung R, Kahlmeyer A, Ivanyi P, Weber F, et al. Journal article Accuracy of colposcopy-directed biopsy in detecting early cervical neoplasia: a retrospective study (2019) Stuebs FA, Schulmeyer CE, Mehlhorn G, Gaß P, Kehl S, Renner SK, Renner S, et al. Journal article Clinical utility of the simplified 15-gene S3-score for prediction of outcome in clear cell renal cell carcinoma (2019) Buettner F, Winter S, Rausch S, Hennenlotter J, Kruck S, Stenzl A, Scharpf M, et al. Conference contribution Analysis of the prognostic relevance of sex-steroid hormonal receptor mRNA expression in muscle-invasive urothelial carcinoma of the urinary bladder (2019) Erben P, Sikic D, Wirtz RM, Martini T, Weis CA, Breyer J, Otto W, et al. Journal article EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees†. (2019) Horwich A, Babjuk M, Bellmunt J, Bruins HM, De Reijke TM, De Santis M, Gillessen S, et al. Journal article Expression of Prostate-specific Membrane Antigen (PSMA) in papillary renal cell carcinoma (pRCC) (2019) Zschaebitz S, Erlmeier F, Stoehr C, Polifka I, Schrader AJ, Hartmann A, Ivanyi P, Steffens S Conference contribution Risk of postmenopausal hormone therapy and patient history factors for the survival rate in women with endometrial carcinoma (2019) Hein A, Schneider M, Renner S, Fasching P, Fießler C, Titz S, Hartmann A, et al. Journal article